Gembardt did not report an upregulation of renal SGLT1 protein levels and differential results on the levels of SGLT1 mRNA in ob/ob diabetic mice under complete SGLT2 blockade. But the observed (incomplete) 30 -50% inhibition of reabsorption by SGLT2 inhibitors appears to be the sum of SGLT1 compensation and residual SGLT2 activity. 4 So, we agree with the authors of the letter that our wording is overstated and thank them for pointing this out. With respect to the second comment about Table 1 , we aimed to review the most important effects of SGLT2 inhibition, and due to space constraints, we had to limit ourselves to effects to key organs. It is correct that SGLT2 is also expressed outside of organs mentioned by (i.e. kidney, brain, thyroid, and heart); we realize that the full list of all organs that express SGLT2 contains .20 organs. 
